Case of buprenorphine-associated central sleep apnea resolving with dose reduction
Journal of Opioid Management · 01.07.2022 · 18 (4) · 391-394
DOI: 10.5055/jom.2022.0732 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Opioid Management, online erschienen am 01.07.2022. Verfasst von Vladimir Tchikrizov und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi. ORCID: https://orcid.org/0000-0002-2429-…. Hauptthemen laut MEDLINE: Buprenorphine, Opioid-Related Disorders, Sleep Apnea Syndromes, Sleep Apnea, Central. Die Arbeit wurde bisher 7-mal zitiert (Crossref).
Abstract (Originalsprache)
Aside from respiratory suppression in overdose, full opioid agonist agents are known to cause sleep-disordered breathing (SDB). The increasing rates of opioid overdose in the United States have led to increasing use of medication-assisted treatments for opioid use disorders. Dose-dependent increase in SDB has been documented with methadone. There is emerging literature in the form of case reports providing evidence of buprenorphine and buprenorphine–naloxone contributing to sleep apnea. We report an additional case of a female patient developing central sleep apnea during initiation of buprenorphine–naloxone treatment. The condition resolved with dose reduction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi. ORCID: https://orcid.org/0000-0002-2429-7529.
- Associate Professor, Psychiatry, Division Director, Sleep Medicine, Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi.
- Medical Director, Center for Innovation & Discovery in Addictions (CIDA), Assistant Professor, Department of Psychiatry & Human Behavior, Jackson, Mississippi. ORCID: https://orcid.org/0000-0002-8845-0182.
Zitieren
APA
Tchikrizov, V., Richert, A. C., & Bhardwaj, S. B. (2022). Case of buprenorphine-associated central sleep apnea resolving with dose reduction. Journal of Opioid Management, 18(4), 391-394. https://doi.org/10.5055/jom.2022.0732
Vancouver
Tchikrizov V, Richert AC, Bhardwaj SB. Case of buprenorphine-associated central sleep apnea resolving with dose reduction. Journal of Opioid Management. 2022;18(4):391-394. doi:10.5055/jom.2022.0732
BibTeX
@article{Tchikrizov2022,
author = {Tchikrizov, Vladimir and Richert, Allen C and Bhardwaj, Saurabh B},
title = {Case of buprenorphine-associated central sleep apnea resolving with dose reduction},
journal = {Journal of Opioid Management},
year = {2022},
volume = {18},
number = {4},
pages = {391--394},
doi = {10.5055/jom.2022.0732}
}
EUVIMED